全文获取类型
收费全文 | 4774篇 |
免费 | 325篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 33篇 |
儿科学 | 136篇 |
妇产科学 | 175篇 |
基础医学 | 666篇 |
口腔科学 | 135篇 |
临床医学 | 387篇 |
内科学 | 1397篇 |
皮肤病学 | 86篇 |
神经病学 | 352篇 |
特种医学 | 98篇 |
外国民族医学 | 3篇 |
外科学 | 627篇 |
综合类 | 67篇 |
一般理论 | 5篇 |
预防医学 | 298篇 |
眼科学 | 50篇 |
药学 | 290篇 |
中国医学 | 9篇 |
肿瘤学 | 294篇 |
出版年
2023年 | 30篇 |
2022年 | 52篇 |
2021年 | 110篇 |
2020年 | 71篇 |
2019年 | 88篇 |
2018年 | 106篇 |
2017年 | 68篇 |
2016年 | 97篇 |
2015年 | 114篇 |
2014年 | 159篇 |
2013年 | 187篇 |
2012年 | 263篇 |
2011年 | 334篇 |
2010年 | 174篇 |
2009年 | 168篇 |
2008年 | 266篇 |
2007年 | 307篇 |
2006年 | 269篇 |
2005年 | 261篇 |
2004年 | 258篇 |
2003年 | 231篇 |
2002年 | 207篇 |
2001年 | 86篇 |
2000年 | 79篇 |
1999年 | 77篇 |
1998年 | 42篇 |
1997年 | 44篇 |
1996年 | 39篇 |
1995年 | 40篇 |
1994年 | 37篇 |
1993年 | 19篇 |
1992年 | 43篇 |
1991年 | 66篇 |
1990年 | 75篇 |
1989年 | 50篇 |
1988年 | 33篇 |
1987年 | 37篇 |
1986年 | 51篇 |
1985年 | 36篇 |
1984年 | 40篇 |
1983年 | 39篇 |
1982年 | 18篇 |
1979年 | 29篇 |
1975年 | 19篇 |
1974年 | 19篇 |
1973年 | 18篇 |
1972年 | 18篇 |
1971年 | 22篇 |
1968年 | 17篇 |
1966年 | 20篇 |
排序方式: 共有5108条查询结果,搜索用时 50 毫秒
991.
Toni M. Diegoli Adrian Linacre Moses S. Schanfield Michael D. Coble 《International journal of legal medicine》2014,128(4):579-587
Though allele frequency data for a variety of X chromosomal short tandem repeat (STR) markers in a range of populations have been reported, fewer studies of mutation rates in these same markers or populations are available. In order to address possible mismatches during kinship analysis due to mutation, a robust estimate of the rate of mutation must be established. Here, mutation rates in three US populations have been determined for a total of 15 markers (DXS6789, DXS9902, DXS7132, DXS7130, DXS6795, DXS10147, DXS8378, DXS7423, HPRTB, DXS101, DXS7424, GATA31E08, GATA172D05, GATA165B12, and DXS6803). Eighteen mutations over 20,625 meioses were observed, and the overall X STR mutation rate in this study was found to be 8.73?×?10?4 (95 % CI, 5.2–13.8?×?10?4). A review of published mutation rate studies revealed similar findings in other global populations, and allowed the compilation of a combined dataset of 81,310 meioses which can be employed by the forensic community. 相似文献
992.
993.
CCR5-Δ32 polymorphism—a possible protective factor from gait impairment amongst post-stroke patients
Jeremy Molad Hen Hallevi Estelle Seyman Ofer Rotschild Natan M. Bornstein Oren Tene Nir Giladi Jeffrey M. Hausdorff Anat Mirelman Einor Ben Assayag 《European journal of neurology》2023,30(3):692-701
Background and purpose
Stroke and small vessel disease cause gait disturbances and falls. The naturally occurring loss-of-function mutation in the C-C chemokine receptor 5 gene (CCR5-Δ32) has recently been reported as a protective factor in post-stroke motor and cognitive recovery. We sought to examine whether it also influences gait and balance measures up to 2 years after stroke.Method
Participants were 575 survivors of first-ever, mild–moderate ischaemic stroke or transient ischaemic attack from the TABASCO prospective study, who underwent a 3 T magnetic resonance imaging at baseline and were examined by a multi-professional team 6, 12 and 24 months after the event, using neurological, neuropsychological and mobility examinations. Gait rhythm and the timing of the gait cycle were measured by force-sensitive insoles. CCR5-Δ32 status and gait measures were available for 335 patients.Results
CCR5-Δ32 carriers (16.4%) had higher gait speed and decreased (better) stride and swing time variability 6 and 12 months after the index event compared to non-carriers (p < 0.01 for all). The association remained significant after adjustment for age, gender, education, ethnicity and stroke severity.Conclusions
Significant associations were found between gait measurements and CCR5-Δ32 loss-of-function mutation amongst stroke survivors. This is the first study showing that genetic predisposition may predict long-term gait function after ischaemic stroke. 相似文献994.
Krishna Reddy KV Mahender Rao S Om Reddy G Suresh T Moses Babu J Dubey PK Vyas K 《Journal of pharmaceutical and biomedical analysis》2002,30(3):635-642
Two unknown impurities in linezolid bulk drug at levels below 0.1% (ranging from 0.05 to 0.1%) were detected by a simple isocratic reverse phase high performance liquid chromatography (HPLC). These impurities were isolated from crude sample of linezolid using reverse phase preparative HPLC. Based on the spectroscopic data (IR, NMR and MS) the structures of the impurities were characterized as (S)-N-[[-(3-(3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl] acetate(I) and (S)-N-[[-(3-(3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl] chloride(II). The synthesis from an unambiguous route and the formation of impurities was discussed. 相似文献
995.
Satyanarayana U Rao DS Kumar YR Babu JM Kumar PR Reddy JT 《Journal of pharmaceutical and biomedical analysis》2004,35(4):951-957
During the impurity profile of Celecoxib, four polar impurities (impurity I, II, III and IV) and one non-polar impurity (impurity V) with respect to Celecoxib were detected by HPLC. LC-MS has been employed in this impurity profile study. The three polar impurities (I, II and III) were found to be process related while impurities (IV and V) turned out to be isomers. The impurities III, IV and V were isolated with the help of preparative HPLC. The structure of impurities III, IV (ortho-isomer) and V (regio-isomer) were confirmed as [5-(4-methylphenyl)-3-trifluoromethyl-1H-pyrazole], 4-[5-(2'-methyl phenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl] benzenesulfonamide, and 4-[4-(4'-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-benzenesulfonamide, respectively. The structures of impurities I, II, III and IV were confirmed by synthesis and structural characterization using spectral data. However, the impurity V was not synthesized. 相似文献
996.
Reddy KV Babu JM Kumar YR Reddy SV Kumar MK Eswaraiah S Reddy KR Reddy MS Bhaskar BV Dubey PK Vyas K 《Journal of pharmaceutical and biomedical analysis》2003,32(1):29-39
Three unknown impurities in loratadine bulk drug at levels below 0.1% (ranging from 0.05 to 0.1%) were detected by a simple isocratic reversed-phase high performance liquid chromatography (HPLC). These impurities were isolated from mother liquor sample of loratadine using reversed-phase preparative HPLC. Based on the spectral data (IR, NMR and MS) the structures of these impurities were characterized as 11-(N-carboethoxy-4-piperidylidene)-6,11-dihydro-5H-benzo(5,6) cyclopenta(1,2-b)-pyridine (I), 8-bromo-11-(N-carboethoxy-4-piperidylidene)-6,11-dihydro-5H-benzo(5,6) cyclopenta (1,2-b)-pyridine (II) and 8-chloro-11-(N-carboethoxy-4-piperidylidene)-5H-benzo(5,6) cyclopenta (1,2-b)-pyridine (III). The synthesis of these impurities was discussed. 相似文献
997.
R Roy D Zurakowski J Wischhusen C Frauenhoffer S Hooshmand M Kulke M A Moses 《British journal of cancer》2014,111(9):1772-1779
Background:
A majority of patients with pancreatic malignancies, including both pancreatic ductal adenocarcinoma (PDAC) and pancreatic neuroendocrine tumours (pNETs), present with advanced disease due to a lack of specific symptoms and current diagnostic limitations, making this disease extremely difficult to detect. Our goal was to determine whether urinary matrix metalloproteases (uMMPs) and/or their endogenous inhibitors, urinary tissue inhibitor of metalloproteases (uTIMPs), could be detected in the urine of patients with pancreatic malignancies and whether they may serve as independent predictors of disease status.Methods:
Retrospective analyses of urine samples (n=139) from PDAC and pNET patients as well as age- and sex-matched controls were conducted. Urinary MMP-2 and uTIMP-1 levels were determined using ELISA and zymography. Biomarker expression in tumour and normal pancreatic tissues was analysed via immunohistochemistry (IHC).Results:
Multivariable logistic regression analyses indicated that, when controlling for age and sex, uMMP-2 (P<0.0001) and uTIMP-1 (P<0.0001) but not uMMP-9, were significant independent predictors for distinguishing between PDAC patients and healthy controls. Our data also indicated that uMMP-2 was an independent predictor of the presence of pNET. In addition, uTIMP-1 levels could differentiate the two cancer groups, PDAC and pNET, respectively. Immunohistochemistry analysis confirmed that MMP-2 and TIMP-1 protein expression is significantly upregulated in PDAC tissue compared with the normal pancreas.Conclusions:
Taken together, our results suggest that the detection of uMMP-2 and uTIMP-1 may have diagnostic value in the detection of pancreatic malignancies and that uTIMP-1 may be useful in distinguishing between pancreatic adenocarcinoma and neuroendocrine tumours. 相似文献998.
The diagnosis of onychomycosis, using direct microscopy and fungal cultures, is often negative despite the presence of disease. Periodic acid-Schiff (PAS) staining of nail clippings, using histopathological processing, may be positive in these cases. It is not always clear, however, whether the fungal elements detected by PAS staining are pathogenic fungi or some are saprophytes. We aimed to study the efficacy of histopathological PAS staining of nail clippings as a second-line diagnostic tool in onychomycosis. The study included 100 consecutive cases in which direct microscopy and fungal cultures from suspected onychomycosis were negative on one occasion or more. The obtained nail clippings were processed for routine histology, stained with hematoxylin and eosin and PAS, and examined microscopically. Of the 100 cases, 38 (38%) showed positive fungal elements. As a result, 9 patients had sought and received oral antifungal therapy and all achieved complete clinical cure. The histological examination also revealed parakeratosis and globules of plasma, which were statistically significantly more common in the fungal infected nail samples. This may indicate an ongoing inflammatory process associated with onychomycosis. Neutrophils and bacteria were not statistically and significantly more common in the fungal infected nails. We conclude that as a second-line diagnostic tool, PAS stain of nail clippings increases markedly the diagnostic yield of onychomycosis and, consequently, the outcome of therapy. 相似文献
999.
Frugier T Conquest A McLean C Currie P Moses D Goldshmit Y 《Journal of neuropathology and experimental neurology》2012,71(3):242-250
Glial scars that consist predominantly of reactive astrocytes create a major barrier to neuronal regeneration after traumatic brain injury (TBI). In experimental TBI, Eph receptors and their ephrin ligands are upregulated on reactive astrocytes at injury sites and inhibit axonal regeneration, but very little is known about Eph receptors in the human brain after TBI. A better understanding of the functions of glial cells and their interactions with inflammatory cells and injured axons will allow the development of treatment strategies that may promote regeneration. We analyzed EphA4 expression and activation in postmortem brain tissue from 19 patients who died after acute closed head injury and had evidence of diffuse axonal injury and 8 controls. We also examined downstream pathways that are mediated by EphA4 in human astrocyte cell cultures. Our results indicate that, after TBI in humans, EphA4 expression is upregulated and is associated with reactive astrocytes. The expression was increased shortly after the injury and remained activated for several days. EphA4 activation induced under inflammatory conditions in vitro was inhibited using unclustered EphA4 ligand. These results suggest that blocking EphA4 activation may represent a therapeutic approach for TBI and other types of brain injuries in humans. 相似文献
1000.